Dwivedi, Durgesh Kumar <br/><br/>
Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  11 2018 
 - 1257-1274 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-018-1540-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chemical and Drug Induced Liver Injury--drug therapy<br/>DNA Damage<br/>Glyburide--pharmacology<br/>Hepatic Stellate Cells--drug effects<br/>Hypoglycemic Agents--pharmacology<br/>Liver--drug effects<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>NLR Family, Pyrin Domain-Containing 3 Protein--metabolism<br/>Protective Agents--pharmacology<br/>Rats, Wistar<br/>Thioacetamide